Beta-blockers and health-related quality of life in patients with peripheral arterial disease and COPD

References

• SinDDAnthonisenNRSorianoJBAgustiAGMortality in COPD: Role of comorbiditiesEur Respir J200661245125717138679
   PubMed Web of Science ®Google Scholar
• ManganoDTLayugELWallaceATateoIEffect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. Multicenter Study of Perioperative Ischemia Research GroupN Engl J Med199623171317208929262
   PubMed Web of Science ®Google Scholar
• PoldermansDBoersmaEBaxJJThe effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study GroupN Engl J Med1999241789179410588963
   PubMed Web of Science ®Google Scholar
• EgredMShawSMohammadBWaittPRodriguesEUnder-use of beta-blockers in patients with ischaemic heart disease and concomitant chronic obstructive pulmonary diseaseQJM2005749349715955798
   PubMed Web of Science ®Google Scholar
• AshrafianHViolarisAGBeta-blocker therapy of cardiovascular diseases in patients with bronchial asthma or COPD: The pro viewpointPrim Care Respir J2005523624116701736
   PubMedGoogle Scholar
• CamsariAArikanSAvanCMetoprolol, a beta-1 selective blocker, can be used safely in coronary artery disease patients with chronic obstructive pulmonary diseaseHeart Vessels2003418819214520486
   PubMed Web of Science ®Google Scholar
• KieranSMCahillRABrowneISheehanSJMehiganDBarryMCThe effect of perioperative beta-blockade on the pulmonary function of patients undergoing major arterial surgeryEur J Vasc Endovasc Surg2006330530816631393
   PubMed Web of Science ®Google Scholar
• SalpeterSOrmistonTSalpeterECardioselective beta-blockers for chronic obstructive pulmonary diseaseCochrane Database Syst Rev20054CD00356616235327
   PubMed Web of Science ®Google Scholar
• SalpeterSROrmistonTMSalpeterEECardioselective beta-blockers in patients with reactive airway disease: a meta-analysisAnn Intern Med2002971572512416945
   PubMed Web of Science ®Google Scholar
• SirakTEJelicSLe JemtelTHTherapeutic update: non-selective beta- and alpha-adrenergic blockade in patients with coexistent chronic obstructive pulmonary disease and chronic heart failureJ Am Coll Cardiol2004349750215358010
   PubMed Web of Science ®Google Scholar
• ChenJRadfordMJWangYMarciniakTAKrumholzHMEffectiveness of beta-blocker therapy after acute myocardial infarction in elderly patients with chronic obstructive pulmonary disease or asthmaJ Am Coll Cardiol200171950195611401137
   PubMed Web of Science ®Google Scholar
• GottliebSSMcCarterRJVogelRAEffect of beta-blockade on mortality among high-risk and low-risk patients after myocardial infarctionN Engl J Med199884894979709041
   PubMed Web of Science ®Google Scholar
• van GestelYRHoeksSESinDDImpact of cardioselective beta-blockers on mortality in patients with chronic obstructive pulmonary disease and atherosclerosisAm J Respir Crit Care Med2008769570018565952
   PubMed Web of Science ®Google Scholar
• RabeKFHurdSAnzuetoAGlobal strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summaryAm J Respir Crit Care Med2007653255517507545
   PubMed Web of Science ®Google Scholar
• WareJEJrSherbourneCDThe MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selectionMed Care199264734831593914
   PubMed Web of Science ®Google Scholar
• AaronsonNKMullerMCohenPDTranslation, validation, and norming of the Dutch language version of the SF-36 Health Survey in community and chronic disease populationsJ Clin Epidemiol199811105510689817123
   PubMed Web of Science ®Google Scholar
• HarperRBrazierJEWaterhouseJCWaltersSJJonesNMHowardPComparison of outcome measures for patients with chronic obstructive pulmonary disease (COPD) in an outpatient settingThorax1997108798879404375
   PubMed Web of Science ®Google Scholar
• MahlerDAMackowiakJIEvaluation of the short-form 36-item questionnaire to measure health-related quality of life in patients with COPDChest19956158515897781351
   PubMed Web of Science ®Google Scholar
• DesikanRMasonHLRuppMTSkehanMHealth-related quality of life and healthcare resource utilization by COPD patients: a comparison of three instrumentsQual Life Res2002873975112482158
   PubMed Web of Science ®Google Scholar
• RumsfeldJSMagidDJPlomondonMEHistory of depression, angina, and quality of life after acute coronary syndromesAm Heart J2003349349912660673
   PubMed Web of Science ®Google Scholar
• SpertusJAJonesPMcDonellMFanVFihnSDHealth status predicts long-term outcome in outpatients with coronary diseaseCirculation20021434912093768
   PubMed Web of Science ®Google Scholar
• DobreDvan JaarsveldCHdeJongsteMJHaaijer RuskampFMRanchorAVThe effect of beta-blocker therapy on quality of life in heart failure patients: a systematic review and meta-analysisPharmacoepidemiol Drug Saf2007215215916555368
   PubMed Web of Science ®Google Scholar
• MascarenhasJLourencoPLopesRAzevedoABettencourtPChronic obstructive pulmonary disease in heart failure. Prevalence, therapeutic and prognostic implicationsAm Heart J2008352152518294490
   PubMed Web of Science ®Google Scholar
• AntmanEMHandMArmstrongPW2007 Focused Update of the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: developed in collaboration With the Canadian Cardiovascular Society endorsed by the American Academy of Family Physicians: 2007 Writing Group to Review New Evidence and Update the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction, Writing on Behalf of the 2004 Writing CommitteeCirculation2008229632918071078
   PubMed Web of Science ®Google Scholar
• D’AgostinoRBJrPropensity score methods for bias reduction in the comparison of a treatment to a non-randomized control groupStat Med19981922652281
   Web of Science ®Google Scholar